Health & Biotech
Check out the latest Medtech news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
Health & Biotech
Health Check: We’ll see you in court and you bladder believe it, says Pacific Edge after unfavourable US ruling
Health & Biotech
Health Check: Did the earth move for you? The world shifts on its axis as it enters the Trump era mark two
Health & Biotech
EBR’s US heart lead hopes tick up after wireless device gets nod for fast-track reimbursement pathway
Health & Biotech
Health Check: Investor hearts pump as EBR girds for US approval of novel pacemaker leads
Stockhead TV
Road to 2025: Clinical trials hit fever pitch for Island Pharmaceuticals
Stockhead TV
Road to 2025: EBR Systems gets ahead of the pacemaker pack
Health & Biotech
Singular Health Group fulfils Phase 1 of US remote medical image aggregation MOU with PNS
Stockhead TV
Road to 2025: Don’t blink and miss this mental healthcare company
Health & Biotech
Biocurious: With its pre-budget ‘wish list’, Ausbiotech prepares to bat for the sector in Canberra
Health & Biotech
Health Check: Local biotech starred in 2024, but the rising tide did not lift all boats
Health & Biotech
Health Check: With yet another customer win, Pro Medicus storms to 2024 finish line with a wet sail
Health & Biotech
Health Check: Telix CEO gets pay bump as company files for US kidney imaging approval
Stockhead TV
Break it Down: Radiopharm Theranostics progresses along path to help heal HER-2 cancer
Health & Biotech
FDA pre-approval inspection of EBR’s WiSE CRT system set for early January
Stockhead TV
Break it Down: BlinkLab’s positive pivot into US market path
Health & Biotech
BlinkLab gains FDA support for trial of app aiding autism diagnosis
Health & Biotech
Health Check: Joy as Mesoblast wins its first FDA approval for a stem-cell therapy after decades of trying
Health & Biotech
Biocurious: Painchek’s aged care and infant market expansion plans could be much-needed salve
Health & Biotech
Health Check: Clinical trials don’t sleigh down for the silly season
Health & Biotech
Biocurious: IPO candidate Nexsen Biotech tackles global infant killer with early diagnosis tool
Health & Biotech
Health Check: Can Syntara produce the next multibillion-dollar Aussie blood cancer drug?
Stockhead TV
Break it Down: ReNerve’s exclusive Middle East move
Health & Biotech
Health Check: The robots are taking over biotech stock selection
Health & Biotech
Health Check: Booming Sonic seals a $700 million German acquisition
Health & Biotech
Health Check: Biotech’s forgotten tortoises pick up the pace as sector emerges from two-year slump
Health & Biotech
Health Check: Pro Medicus founders cashed up for the festive season
Health & Biotech
Biocurious: Armed with a lucky payment number, Control Bionics plots its US expansion
Health & Biotech
Health Check: Let there be light (therapy). Invion up 160pc on skin cancer trial news
Stockhead TV
Break it Down: Orthocell’s pivotal path into US healthcare market
Health & Biotech
Imricor performs first atrial flutter ablation at Swiss hospital
Stockhead TV
Break it Down: Cleo Diagnostics partnership to bring new hope for ovarian cancer detection
Health & Biotech
Medical imaging stock Singular Health seals US deal and locks in $3.7m raise
Health & Biotech
Optiscan inks deal with US uni to diagnose cancer in animals
Health & Biotech
Biocurious: From drug prices to efficiency drives, ASX biotechs await the ‘Trumpcare’ health fallout
Health & Biotech
BlinkLab rises on positive results of autism study
Health & Biotech
EBR reports milestone quarter, final FDA review for WiSE CRT system
Health & Biotech
BlinkLab joins ‘landmark’ Monash University autism/ADHD project
Health & Biotech
Optiscan inks deal with Monash Uni to progress GI scope
Health & Biotech
Dr Boreham’s Crucible: Can this cancer drug developer hit right notes for commercial success?
Health & Biotech
Basement to Breakthrough: Imricor transforms heart treatment with MRI
Stockhead TV
Long Shortz with Optiscan: OIL targets massive US veterinary market at major healthcare events
Stockhead TV
Long Shortz with Orthocell: Nerve repair product ready for US domination on $17M raise
Health & Biotech
Dr Boreham’s Crucible: Can this nuclear medicine play’s tech explode in the US?
Stockhead TV
Long Shortz with Aroa Biosurgery: Puzzle pieces coming together for success in H2 FY25
Health & Biotech
EBR seeks key WiSE US reimbursement
Health & Biotech
Health Check: Rats – and investors – are happy as Nyrada forges ahead with its first human trial
Health & Biotech
Biocurious: Optiscan aims for cancer surgery to be done right all the time, first time
Load More